
ReShape Lifesciences Inc - Product Pipeline Analysis, 2022 Update
Description
Summary
ReShape Lifesciences Inc (ReShape) formerly EnteroMedics Inc, is a medical technology company. It designs, develops and commercializes minimally invasive medical devices to treat obesity and metabolic diseases. The company offers vBloc, a therapy used in the treatment of gastrointestinal and neurometabolic diseases; ReShape Balloon System, a non-invasive weight loss solution used for patients failed at diet and exercise; and ReShape Vest, a laparoscopically implanted medical device that enable weight loss and stomach preservation in obese and morbidly obese patients. ReShape is headquartered in San Clemente, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
ReShape Lifesciences Inc (ReShape) formerly EnteroMedics Inc, is a medical technology company. It designs, develops and commercializes minimally invasive medical devices to treat obesity and metabolic diseases. The company offers vBloc, a therapy used in the treatment of gastrointestinal and neurometabolic diseases; ReShape Balloon System, a non-invasive weight loss solution used for patients failed at diet and exercise; and ReShape Vest, a laparoscopically implanted medical device that enable weight loss and stomach preservation in obese and morbidly obese patients. ReShape is headquartered in San Clemente, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ReShape Lifesciences Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
35 Pages
- ReShape Lifesciences Inc Company Overview
- ReShape Lifesciences Inc Company Snapshot
- ReShape Lifesciences Inc Pipeline Products and Ongoing Clinical Trials Overview
- ReShape Lifesciences Inc – Pipeline Analysis Overview
- ReShape Lifesciences Inc - Key Facts
- ReShape Lifesciences Inc - Major Products and Services
- ReShape Lifesciences Inc Pipeline Products by Development Stage
- ReShape Lifesciences Inc Ongoing Clinical Trials by Trial Status
- ReShape Lifesciences Inc Pipeline Products Overview
- Diabetes Bloc-Stim Neuromodulation Device
- Diabetes Bloc-Stim Neuromodulation Device Product Overview
- Diabetes Bloc-Stim Neuromodulation Device - Hypoglycemia
- Diabetes Bloc-Stim Neuromodulation Device - Hypoglycemia Product Overview
- Maestro RF System
- Maestro RF System Product Overview
- Patient Compliance System
- Patient Compliance System Product Overview
- ReShape Vest
- ReShape Vest Product Overview
- ReShape Vest Clinical Trial
- ReShape Lifesciences Inc - Key Competitors
- ReShape Lifesciences Inc - Key Employees
- ReShape Lifesciences Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- ReShape Lifesciences Inc, Recent Developments
- Nov 14, 2022: ReShape Lifesciences Reports Third Quarter 2022 Financial Results and Provides Corporate Update
- Nov 07, 2022: ReShape Lifesciences to Announce Financial Results for the Third Quarter Ended September 30, 2022, and Provide Corporate Update
- Aug 15, 2022: ReShape Lifesciences Reports Second Quarter 2022 Financial Results and Provides Corporate Update
- Aug 10, 2022: ReShape Lifesciences to Announce Financial Results for the Second Quarter Ended June 30, 2022 and Provide Corporate Update
- May 23, 2022: ReShape Lifesciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
- May 16, 2022: ReShape Lifesciences to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update
- Mar 31, 2022: ReShape Lifesciences™ to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update
- Mar 28, 2022: ReShape Lifesciences Reports Year Ended 2021 Financial and Operating Results and Provides Corporate Update
- Nov 11, 2021: ReShape Lifesciences Reports Third Quarter and Nine Month 2021 Financial and Operational Results
- Nov 08, 2021: ReShape Lifesciences to Report Third Quarter 2021 Financial and Operational Results on Thursday, November 11, 2021
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Table 1: ReShape Lifesciences Inc Pipeline Products and Ongoing Clinical Trials Overview
- Table 2: ReShape Lifesciences Inc Pipeline Products by Equipment Type
- Table 3: ReShape Lifesciences Inc Pipeline Products by Indication
- Table 4: ReShape Lifesciences Inc, Key Facts
- Table 5: ReShape Lifesciences Inc, Major Products and Services
- Table 6: ReShape Lifesciences Inc Number of Pipeline Products by Development Stage
- Table 7: ReShape Lifesciences Inc Pipeline Products Summary by Development Stage
- Table 8: ReShape Lifesciences Inc Ongoing Clinical Trials by Trial Status
- Table 9: ReShape Lifesciences Inc Ongoing Clinical Trials Summary
- Table 10: Diabetes Bloc-Stim Neuromodulation Device - Product Status
- Table 11: Diabetes Bloc-Stim Neuromodulation Device - Product Description
- Table 12: Diabetes Bloc-Stim Neuromodulation Device - Hypoglycemia - Product Status
- Table 13: Diabetes Bloc-Stim Neuromodulation Device - Hypoglycemia - Product Description
- Table 14: Maestro RF System - Product Status
- Table 15: Maestro RF System - Product Description
- Table 16: Patient Compliance System - Product Status
- Table 17: Patient Compliance System - Product Description
- Table 18: ReShape Vest - Product Status
- Table 19: ReShape Vest - Product Description
- Table 20: ReShape Vest - An Investigative, Prospective, Non-randomized, Multi-center Study to Assess the Safety and Effectiveness of a Novel Gastric Restrictive Device, Call the ReShape Vest, in People Who Are Obese
- Table 21: ReShape Lifesciences Inc, Key Employees
- Table 22: ReShape Lifesciences Inc, Subsidiaries
- Table 23: Glossary
- List of Figures
- Figure 1: ReShape Lifesciences Inc Pipeline Products by Equipment Type
- Figure 2: ReShape Lifesciences Inc Pipeline Products by Development Stage
- Figure 3: ReShape Lifesciences Inc Ongoing Clinical Trials by Trial Status
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.